Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Lingvay and her international colleagues collaborated in the Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity Trial (SELECT)
October 16, 2025: Rybelsus Patients Have Higher Risk of Kidney Problems Than Tirzepatide A new study has found that semaglutide drugs, like Rybelsus, are associated with a higher rate of acute kidney injury than other types of GLP-1 drugs
Could New Weight-Loss Drugs like Ozempic Treat Addiction
A prior authorization request is approved
These results confirm that, consistent clinical observations in human specimens, mouse RMC tumor cells upregulate myeloid lineage markers and undergo hyperprogression in response to ICT
Semaglutide might be better for you if You have type 2 diabetes (additional blood sugar benefits) You prefer a medication with longer clinical history You want proven, consistent results Insurance covers semaglutide but not tirzepatide Tirzepatide might be better for you if You want potentially greater weight loss Youve tried semaglutide without optimal results You have both weight and blood sugar concerns You can tolerate potentially higher initial costs Both medications work best for people who Have a BMI of 30 or higher (or 27+ with weight-related health conditions) Are committed to lifestyle changes Can handle weekly injections Want non-surgical weight loss treatment
